NVM5
Device
NUVASIVE, INC.
Total Payments
$1.5M
Transactions
736
Doctors
431
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $64,121 | 64 | 48 |
| 2023 | $135,259 | 45 | 29 |
| 2022 | $78,486 | 34 | 24 |
| 2021 | $256,796 | 57 | 40 |
| 2020 | $288,149 | 89 | 68 |
| 2019 | $123,863 | 115 | 96 |
| 2018 | $228,556 | 207 | 128 |
| 2017 | $320,574 | 125 | 88 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $1.4M | 93 | 93.6% |
| Unspecified | $49,184 | 27 | 3.3% |
| Food and Beverage | $27,972 | 579 | 1.9% |
| Consulting Fee | $12,638 | 3 | 0.8% |
| Travel and Lodging | $6,042 | 32 | 0.4% |
| Entertainment | $10.00 | 2 | 0.0% |
Payments by Type
General
$1.4M
709 transactions
Research
$49,184
27 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NUVA.NV1401 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health | NUVASIVE, INC. | $35,638 | 0 |
| NUVA.NV1401 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health | NuVasive, Inc. | $11,301 | 3 |
| NUVA.NV1301 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health | NuVasive, Inc. | $2,000 | 0 |
| NUVA.AX1401 AttraX Putty vs. Autograft in eXtreme Lateral Interbody Fusion XLIF A Prospective Randomized Single-Center Evaluation of Radiographic and Clinical Outcomes | NuVasive, Inc. | $245.00 | 0 |
Top Doctors Receiving Payments for NVM5 — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Neurological Surgery | Charlottesville, VA | $154.22 | 2 |
| , MD | Orthopaedic Surgery | Willow Grove, PA | $150.74 | 1 |
| , MD | Orthopaedic Surgery | Philadelphia, PA | $150.74 | 1 |
| , D.O | Neurology | New York, NY | $149.89 | 3 |
| , MD | Neurological Surgery | Eugene, OR | $149.71 | 1 |
| , MD | Neurological Surgery | Charlottesville, VA | $148.69 | 2 |
| , M.D | Student in an Organized Health Care Education/Training Program | Birmingham, AL | $148.19 | 1 |
| David Briski | Orthopaedic Surgery | Greer, SC | $144.89 | 1 |
| , PA-C | Physician Assistant | Greer, SC | $144.88 | 1 |
| , MD | Orthopaedic Surgery | Scottsdale, AZ | $144.36 | 3 |
| , MD | Neurological Surgery | Charlotte, NC | $142.36 | 1 |
| , MD | Neurological Surgery | Radnor, PA | $137.85 | 1 |
| , M.D | Neurological Surgery | Reading, PA | $137.85 | 1 |
| Nicole Molin | Otolaryngology | Philadelphia, PA | $137.85 | 1 |
| , M.D | Neurological Surgery | South Bend, IN | $137.85 | 1 |
| , M.D | Neurological Surgery | Tucson, AZ | $136.77 | 2 |
| , M.D | Specialist | Phoenix, AZ | $133.54 | 1 |
| , MD | Orthopaedic Surgery of the Spine | Gilbert, AZ | $133.54 | 1 |
| , M.D., INC | Orthopaedic Surgery of the Spine | Chicago, IL | $133.53 | 1 |
| , MD | Orthopaedic Surgery | Boston, MA | $133.53 | 1 |
| , MD | Specialist | Phoenix, AZ | $133.53 | 1 |
| , M.D | Pain Medicine | Nottingham, MD | $132.32 | 1 |
| , MD | Anesthesiology | Clifton, NJ | $131.67 | 2 |
| , M.D | Neurological Surgery | Houston, TX | $130.58 | 1 |
| , M.D | Physical Medicine & Rehabilitation | Birmingham, AL | $130.00 | 1 |
Ad
Manufacturing Companies
- NuVasive, Inc. $1.1M
- NUVASIVE, INC. $314,099
- Globus Medical, Inc. $64,121
Product Information
- Type Device
- Total Payments $1.5M
- Total Doctors 431
- Transactions 736
About NVM5
NVM5 is a device associated with $1.5M in payments to 431 healthcare providers, recorded across 736 transactions in the CMS Open Payments database. The primary manufacturer is NUVASIVE, INC..
Payment data is available from 2017 to 2024. In 2024, $64,121 was paid across 64 transactions to 48 doctors.
The most common payment nature for NVM5 is "Royalty or License" ($1.4M, 93.6% of total).
NVM5 is associated with 4 research studies, including "NUVA.NV1401 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health" ($35,638).